Non-interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions
Latest Information Update: 07 Jun 2021
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer; Carcinoma
- Focus Therapeutic Use
- Acronyms JONAS
- 02 Jun 2021 Status changed from active, no longer recruiting to completed.
- 26 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Apr 2017 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.